Meda Pharma S.p.A.
IT-MF-000012233 · Italy · Milano
Meda Pharma S.p.A. is registered in the European database on medical devices as a manufacturer, with 61 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class IIa | 34 |
|---|---|
| Class IIb | 25 |
| Class I | 2 |
Among these devices, 2 are declared sterile.
Devices declared under this manufacturer
- BETADINE Zalfgazen
- Disnemar
- EndWarts ORIGINAL
- EndWarts PEN C
- Ialumar Flaconcini
- Ialumar Soluzione Ipertonica Spray
- Ialumar Soluzione Isotonica Spray
- Kamillosan Ocean Nasendusche
- Linicin ULTRA Shampoo
- Naloc Pro
- OBJECTIF ZEROVERRUE ORIGINAL
- Prioderm Dimeticon Lotion
Showing 12 of 61 declared devices.
Catalogue references include N.A..
European nomenclature codes declared: M0412, Q030103, V901001, U0803, M02030202, Q03040201.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 61 |
| Country of registration | Italy |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 60 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. Meda Pharma S.p.A. was not found in either the U.S. or the Canadian register.
Notified body certificates
| Certificate | Status | Expiry |
|---|---|---|
64326 | issued | 2031-06-24 |
61919 | amended | 2030-06-05 |
61109 | issued | 2030-06-03 |
58863 | amended | 2030-03-17 |